Elawyers Elawyers
Washington| Change

Asahi Kasei Pharma Corporation v. Endo Ventures Limited, 19 Civ. 9060 (LGS). (2019)

Court: District Court, S.D. New York Number: infdco20191231b73 Visitors: 9
Filed: Dec. 30, 2019
Latest Update: Dec. 30, 2019
Summary: ORDER LORNA G. SCHOFIELD , District Judge . WHEREAS, on December 27, 2019, Plaintiff filed a letter outlining a summary of outstanding issues in the litigation (Dkt. No. 52), including a statement that Plaintiff seeks to file supplemental material regarding the issue of irreparable harm in support of its motion for a preliminary injunction, that the parties are seeking to agree, and that in the absence of agreement, Plaintiff will file a letter motion by December 31, 2019. It is hereby ORD
More

ORDER

WHEREAS, on December 27, 2019, Plaintiff filed a letter outlining a summary of outstanding issues in the litigation (Dkt. No. 52), including a statement that Plaintiff seeks to file supplemental material regarding the issue of irreparable harm in support of its motion for a preliminary injunction, that the parties are seeking to agree, and that in the absence of agreement, Plaintiff will file a letter motion by December 31, 2019. It is hereby

ORDERED that, in the event the parties do not agree on the supplemental submission, Plaintiff shall file a copy of the submission as an attachment to its application to file it by December 31, 2019.

ORDERED that the parties shall appear for a conference with the Court on January 7, 2020, at 10:45 a.m. to discuss the issues raised in the letter. The parties may appear by telephone and shall do so by calling Chambers from a landline, with all participating counsel on the line and notifying Courtroom Deputy James Street at James_Street@nysd.uscourts.gov.

Source:  Leagle

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer